These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35194061)

  • 41. Stability of alcohol-free theophylline liquid repackaged in plastic oral syringes.
    Johnson CE; Drabik BT
    Am J Hosp Pharm; 1989 May; 46(5):980-1. PubMed ID: 2729305
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Three-month outcome of ziv-aflibercept for exudative age-related macular degeneration.
    Mansour AM; Chhablani J; Antonios RS; Yogi R; Younis MH; Dakroub R; Chahine H
    Br J Ophthalmol; 2016 Dec; 100(12):1629-1633. PubMed ID: 27030277
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stability of ceftazidime (with arginine) stored in plastic syringes at three temperatures.
    Nahata MC; Morosco RS; Fox JL
    Am J Hosp Pharm; 1992 Dec; 49(12):2954-6. PubMed ID: 1481800
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ziv-aflibercept (Zaltrap) for the treatment of metastatic colorectal cancer.
    Perkins SL; Cole SW
    Ann Pharmacother; 2014 Jan; 48(1):93-8. PubMed ID: 24259608
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A phase II multicentre study of ziv-aflibercept in combination with cisplatin and pemetrexed in patients with previously untreated advanced/metastatic non-squamous non-small cell lung cancer.
    Chen H; Modiano MR; Neal JW; Brahmer JR; Rigas JR; Jotte RM; Leighl NB; Riess JW; Kuo CJ; Liu L; Gao B; Dicioccio AT; Adjei AA; Wakelee HA
    Br J Cancer; 2014 Feb; 110(3):602-8. PubMed ID: 24292447
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stability and sterility of biosynthetic human insulin stored in plastic insulin syringes for 28 days.
    Tarr BD; Campbell RK; Workman TM
    Am J Hosp Pharm; 1991 Dec; 48(12):2631-4. PubMed ID: 1814206
    [TBL] [Abstract][Full Text] [Related]  

  • 47. INTRAVITREAL INJECTIONS OF ZIV-AFLIBERCEPT FOR THE TREATMENT OF A PATIENT WITH MACULAR EDEMA SECONDARY TO BRANCH RETINAL VEIN OCCLUSION.
    Andrade GC; Dias JRO; Maia A; Farah ME; Mitne S; Rodrigues EB
    Retin Cases Brief Rep; 2018 Spring; 12(2):93-96. PubMed ID: 29554051
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Systemic levels of vascular endothelial growth factor before and after intravitreal injection of aflibercept or ranibizumab in patients with age-related macular degeneration: a randomised, prospective trial.
    Zehetner C; Kralinger MT; Modi YS; Waltl I; Ulmer H; Kirchmair R; Bechrakis NE; Kieselbach GF
    Acta Ophthalmol; 2015 Mar; 93(2):e154-9. PubMed ID: 25488124
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CLINICAL AND ELECTROPHYSIOLOGICAL EVALUATION AFTER INTRAVITREAL ZIV-AFLIBERCEPT FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION.
    de Oliveira Dias JR; de Andrade GC; Kniggendorf VF; Novais EA; Maia A; Meyer C; Watanabe SES; Farah ME; Rodrigues EB
    Retina; 2017 Aug; 37(8):1499-1507. PubMed ID: 27798520
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Viability of Primary Human Pigment Epithelium Cells and Muller-Glia Cells after Intravitreal Ziv-Aflibercept and Aflibercept.
    Costa de Andrade G; Wertheimer C; Eibl K; Wolf A; Kampik A; Buchele Rodrigues E; Farah ME; Haritoglou C
    Ophthalmologica; 2016; 236(4):223-227. PubMed ID: 27997919
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Southwest Oncology Group S0802: a randomized, phase II trial of weekly topotecan with and without ziv-aflibercept in patients with platinum-treated small-cell lung cancer.
    Allen JW; Moon J; Redman M; Gadgeel SM; Kelly K; Mack PC; Saba HM; Mohamed MK; Jahanzeb M; Gandara DR
    J Clin Oncol; 2014 Aug; 32(23):2463-70. PubMed ID: 25002722
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safety profiles of anti-VEGF drugs: bevacizumab, ranibizumab, aflibercept and ziv-aflibercept on human retinal pigment epithelium cells in culture.
    Malik D; Tarek M; Caceres del Carpio J; Ramirez C; Boyer D; Kenney MC; Kuppermann BD
    Br J Ophthalmol; 2014 Jun; 98 Suppl 1(Suppl 1):i11-16. PubMed ID: 24836865
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of Intravitreal Aflibercept on Galectin-1 and Vascular Endothelial Growth Factor-A Plasma Levels in Patients with Diabetic Retinopathy.
    Waltl I; Zehetner C; Seifarth C; Handle F; Kieselbach GF; Angermann R; Kralinger MT
    Curr Eye Res; 2018 Mar; 43(3):368-375. PubMed ID: 29172741
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Safety and Efficacy of Ziv-Aflibercept in the Treatment of Refractory Diabetic Macular Edema.
    Ashraf M; Kayal HE; Souka AAR
    Ophthalmic Surg Lasers Imaging Retina; 2017 May; 48(5):399-405. PubMed ID: 28499051
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stability of dicloxacillin sodium oral suspension stored in polypropylene syringes.
    Sylvestri MF; Makoid MC; Adams SC
    Am J Hosp Pharm; 1987 Jun; 44(6):1401-5. PubMed ID: 3618620
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term outcome of treat and extend intravitreal ziv-aflibercept therapy.
    Mansour AM; Charbaji A; Farah ME; Mansour HA; Chhablani J
    Br J Ophthalmol; 2019 Jul; 103(7):938-941. PubMed ID: 30072436
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bevacizumab for Intravitreal Injection: Impact of Sub-Visible Particles on the Shelf-Life of Repackaged Bevacizumab.
    Crul M; Zandvliet A; Moes JR; Veenbaas T; Smeets O
    J Ocul Pharmacol Ther; 2019; 35(6):372-375. PubMed ID: 31259653
    [No Abstract]   [Full Text] [Related]  

  • 58. Stability of cisatracurium besylate in vials, syringes, and infusion admixtures.
    Xu QA; Zhang YP; Trissel LA; Gilbert DL; Martinez JF; Fox JL
    Am J Health Syst Pharm; 1998 May; 55(10):1037-41. PubMed ID: 9606456
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Qualitative differences between ranibizumab from original and ready to use syringes].
    Grisanti S; Tura A
    Ophthalmologe; 2010 Dec; 107(12):1123-32. PubMed ID: 21153577
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intact charge variant analysis of ziv-aflibercept by cationic exchange liquid chromatography as a proof of concept: Comparison between volatile and non-volatile salts in the mobile phase.
    Pérez-Robles R; Cuadros-Rodríguez L; Salmerón-García A; Cabeza-Barrera J; Navas N
    J Pharm Biomed Anal; 2020 Jun; 185():113233. PubMed ID: 32169790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.